This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Xiaozhong Liang: Innovator in Pharmaceutical Formulations
Introduction
Xiaozhong Liang is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 2 patents. His work focuses on innovative solutions for treating and preventing diseases.
Latest Patents
Liang's latest patents include pharmaceutical formulations of a substituted diaminopurine. These formulations comprise 4-((9-((3S)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)-trans-cyclohexanol, which includes pharmaceutically acceptable salts, solvates, isomers, isotopologues, tautomers, and racemic mixtures thereof, along with a pharmaceutically acceptable excipient. These formulations are designed for the treatment or prevention of various diseases.
Career Highlights
Xiaozhong Liang is currently employed at Signal Pharmaceuticals, Inc., where he continues to develop innovative pharmaceutical solutions. His expertise in the field has led to advancements that benefit the medical community and patients alike.
Collaborations
Liang has collaborated with notable colleagues, including Anthony Frank and Anthony J Tutino, contributing to a dynamic work environment that fosters innovation and creativity.
Conclusion
Xiaozhong Liang's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His patents reflect a dedication to improving health outcomes through innovative solutions.